Similar articles

• Intralesional Certolizumab for Refractory Lupus Pernio.

  Dunn C, Whitney Z, Foss M, Ambur A, Eubanks S, Leavitt A, Nathoo R. Dunn C, et al. JAMA Dermatol. 2023 Aug 1;159(8):890-891. doi: 10.1001/jamadermatol.2023.0987. JAMA Dermatol. 2023. PMID: 37314762
• Chilblain lupus erythematosus associated with systemic and discoid lupus erythematosus.

  Cardenas-de la Garza JA, Arvizu-Rivera RI, Ocampo-Candiani J, Galarza-Delgado DA. Cardenas-de la Garza JA, et al. Rheumatology (Oxford). 2021 Feb 1;60(2):988. doi: 10.1093/rheumatology/keaa385. Rheumatology (Oxford). 2021. PMID: 32856084 No abstract available.
• Osseous sarcoidosis with lupus pernio.

  Arora S, Mathuram AJ. Arora S, et al. Indian J Med Res. 2017 Oct;146(4):548-549. doi: 10.4103/ijmr.IJMR_1123_16. Indian J Med Res. 2017. PMID: 29434072 Free PMC article. No abstract available.
• Chilblains in immune-mediated inflammatory diseases: a review.

  Dubey S, Joshi N, Stevenson O, Gordon C, Reynolds JA. Dubey S, et al. Rheumatology (Oxford). 2022 Nov 28;61(12):4631-4642. doi: 10.1093/rheumatology/keac231. Rheumatology (Oxford). 2022. PMID: 35412601 Free PMC article. Review.
• Cutaneous sarcoidosis: Lupus pernio and more.

  Randhawa KS, Lee BW, Micali G, Benson BE, Schwartz RA. Randhawa KS, et al. Ital J Dermatol Venerol. 2022 Jun;157(3):220-227. doi: 10.23736/S2784-8671.21.07027-4. Epub 2022 Mar 11. Ital J Dermatol Venerol. 2022. PMID: 35274876 Review.